ticlopidine has been researched along with Helicobacter Infections in 15 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or aspirin, regarding the prophylaxis of gastroduodenal ulcer disease." | 7.78 | [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. ( Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W, 2012) |
| "From January 2012 to 2016, long-termed thienopyridine users with a peptic ulcer history who did not have peptic ulcers at initial endoscopy were randomly assigned to receive either famotidine (40 mg, before bedtime) or placebo (before bedtime) for 6 months." | 5.24 | Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. ( Chen, WC; Cheng, JS; Hsu, PI; Kao, SS; Lai, KH; Liu, CP; Tsai, KW; Tsai, TJ; Tsay, FW; Wang, HM; Wu, DC, 2017) |
| " Patients with Helicobacter pylori infection and a history of peptic ulcer were assigned dual antiplatelet combination with omeprazole." | 5.17 | Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting. ( Chen, G; Du, Y; Hang, L; Ma, B, 2013) |
| "Low-dose aspirin (ASA) has emerged as one of the most important causes of peptic ulcer bleeding in developed countries." | 3.78 | Anti-platelet therapy and managing ulcer risk. ( Chan, FK, 2012) |
| " In the management of aspirin-related uncomplicated peptic ulcers in patients requiring antiplatelet therapies, continuing aspirin plus a powerful proton pump inhibitor is the choice of treatment." | 3.78 | New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. ( Hsu, PI, 2012) |
| "This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or aspirin, regarding the prophylaxis of gastroduodenal ulcer disease." | 3.78 | [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. ( Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W, 2012) |
| "The frequencies of hemorrhagic spots, erosions and peptic ulcers in the symptomatic clopidogrel users were 25%, 39% and 39%, respectively." | 3.78 | Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy. ( Chan, HH; Chang, SN; Hsiao, SH; Hsu, PI; Huang, HR; Lai, KH; Lin, CH; Lin, CK; Lin, KH; Liu, CP; Tsai, TJ; Tsay, FW; Wang, HM; Wang, KM; Yu, HC, 2012) |
| " pylori-positive and 10-negative subjects) with 100 mg aspirin plus 75 mg clopidogrel (AC) once-daily dosing and AC plus 20 mg famotidine twice-daily dosing (ACH)." | 2.79 | Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine. ( Furuta, T; Ichikawa, H; Iwaizumi, M; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, B | 1 |
| Hang, L | 1 |
| Chen, G | 1 |
| Du, Y | 1 |
| Uotani, T | 1 |
| Sugimoto, M | 1 |
| Nishino, M | 1 |
| Ichikawa, H | 1 |
| Sahara, S | 1 |
| Yamade, M | 1 |
| Iwaizumi, M | 1 |
| Yamada, T | 1 |
| Osawa, S | 1 |
| Sugimoto, K | 1 |
| Umemura, K | 1 |
| Watanabe, H | 1 |
| Miyajima, H | 1 |
| Furuta, T | 1 |
| Lanas, A | 2 |
| Gargallo, CJ | 1 |
| Hsu, PI | 3 |
| Wu, DC | 1 |
| Tsay, FW | 2 |
| Cheng, JS | 1 |
| Liu, CP | 2 |
| Lai, KH | 2 |
| Chen, WC | 1 |
| Wang, HM | 2 |
| Tsai, TJ | 2 |
| Tsai, KW | 1 |
| Kao, SS | 1 |
| Bhatt, DL | 1 |
| Scheiman, J | 1 |
| Abraham, NS | 1 |
| Antman, EM | 1 |
| Chan, FK | 2 |
| Furberg, CD | 1 |
| Johnson, DA | 2 |
| Mahaffey, KW | 1 |
| Quigley, EM | 1 |
| Harrington, RA | 1 |
| Bates, ER | 1 |
| Bridges, CR | 1 |
| Eisenberg, MJ | 1 |
| Ferrari, VA | 1 |
| Hlatky, MA | 1 |
| Kaul, S | 1 |
| Lindner, JR | 1 |
| Moliterno, DJ | 1 |
| Mukherjee, D | 1 |
| Schofield, RS | 1 |
| Rosenson, RS | 1 |
| Stein, JH | 1 |
| Weitz, HH | 1 |
| Wesley, DJ | 1 |
| Nardulli, G | 1 |
| Dai, X | 1 |
| Makaryus, AN | 1 |
| Makaryus, JN | 1 |
| Jauhar, R | 1 |
| Luo, JC | 1 |
| Bae, SE | 1 |
| Kim, SE | 1 |
| Jung, SA | 1 |
| Yoon, SY | 1 |
| Shim, KN | 1 |
| Jung, HK | 1 |
| Kim, TH | 1 |
| Yoo, K | 1 |
| Moon, IH | 1 |
| Schneider, AR | 1 |
| Armbruster, S | 1 |
| Mann, J | 1 |
| von Römer, W | 1 |
| Schuster, T | 1 |
| Schepp, W | 1 |
| Lin, CK | 1 |
| Chan, HH | 1 |
| Yu, HC | 1 |
| Lin, KH | 1 |
| Wang, KM | 1 |
| Chang, SN | 1 |
| Hsiao, SH | 1 |
| Huang, HR | 1 |
| Lin, CH | 1 |
| Stiefelhagen, P | 1 |
4 reviews available for ticlopidine and Helicobacter Infections
| Article | Year |
|---|---|
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combi | 2015 |
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal | 2009 |
Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Aspirin; Clopidogrel; Coro | 2009 |
Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiology; Cardiovascular Dise | 2005 |
3 trials available for ticlopidine and Helicobacter Infections
| Article | Year |
|---|---|
Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
Topics: Angiography; Aspirin; Breath Tests; Carotid Arteries; Carotid Stenosis; Clopidogrel; Drug Interactio | 2013 |
Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.
Topics: Adult; Anti-Ulcer Agents; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy | 2014 |
Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atherosclerosis; Clopidogrel; Double-Blind Method; F | 2017 |
8 other studies available for ticlopidine and Helicobacter Infections
| Article | Year |
|---|---|
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combina | 2008 |
Gastroprotective strategy in aspirin users.
Topics: Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hum | 2009 |
[The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; | 2011 |
Anti-platelet therapy and managing ulcer risk.
Topics: Animals; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Combined Modali | 2012 |
New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Helic | 2012 |
[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Clopid | 2012 |
Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endoscopy, Gastrointestinal; Female; Gastrointestinal | 2012 |
[Gastroenterology in family practice. Updates for your "stomach patient"].
Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Dyspepsia; Esophagitis, Peptic; Family Practice; Heartburn; | 2006 |